Skip to main content

Articles

Page 1 of 16

  1. Access to safe, effective, affordable, and high-quality medications has been included in the Sustainable Development Goals (SDGs) of the United Nations as a crucial step towards attaining universal health cove...

    Authors: Justin Deng, Augustino Ting Mayai, Egide Kayitare, Theoneste Ntakirutimana, Omary Swallehe and Thomas Bizimana
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:172
  2. Successful Vaccine uptake relies heavily on the effectiveness of vaccination services. Expanding the scope of pharmacists’ involvement in vaccination services can significantly improve vaccination coverage. Th...

    Authors: Faten Naif Aldajani and Mohammed Aldosari
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:171
  3. As the needs for home care increase, contact with patients and jobs out of the pharmacy such as the patients’ homes have increased, and there is concern that the situation increases pharmacists’ work-related s...

    Authors: Ayana Kani, Manako Hanya, Hiroyuki Kamei and Kenta Murotani
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:170
  4. The COVID-19 pandemic globally impacted healthcare provision. Prescribing changes in common medications can be used as a marker for new diagnoses. We describe how the prescribing of specific psychotropics was ...

    Authors: Unaiza Waheed, Mike Stedman, Mark Davies, Emma Solomon, David Taylor, Adrian Heald, Ram Prakash Narayanan and John Warner-Levy
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:169
  5. Self-medication and lack of patient adherence contribute to antibiotic misuse. This article describes parents’ attitudes and practices regarding use of antibiotics by their children in Kosovo.

    Authors: Miradije Imeri, Shaip Krasniqi, Lul Raka, Isme Humolli, Kreshnik Hoti, Zana Imeri and Valbona Zhjeqi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:168
  6. Pharmacogenetic (PGx) testing before initiation of thiopurine treatment and CBC monitoring post-initiation helps avoid adverse events and ensure patient safety. This study aims to evaluate trends in PGx testin...

    Authors: Nai-Chung Nelson Chang, Catherine Chanfreau-Coffinier, Jill Bates, Sony Tuteja, Tori R. Anglin, Von R. Moore, Jason Hou, Akbar Waljee, Kathryn M. Pridgen, David W. Oslin, Deepak Voora, Scott L. DuVall, Francesca E. Cunningham and Julie A. Lynch
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:166
  7. Pharmaceutical companies are increasingly leveraging machine learning techniques to optimize healthcare research, drug development, and medical affairs activities. AI (artificial intelligence) tools such as ch...

    Authors: Karen Ka Yan Ng and Peter Chengming Zhang
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:165
  8. Older patients are fragile and more susceptible to medication-related problems requiring a strict assessment of their medicine list. The present study was conducted with the intention to assess the quality use...

    Authors: Behailu Terefe Tesfaye, Dula Dessalegn Bosho, Gashahun Mekonnen Dissassa, Mikiyas Gashaw Tesfaye and Mengist Awoke Yizengaw
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:164
  9. Medication shortage is a public health problem, affecting patients’ outcomes mainly through the difficulty in maintaining adherence, particularly in the context of a severe economic crisis. There is a need for...

    Authors: Sandrella Bou Malhab, Chadia Haddad, Hala Sacre, Aline Hajj, Rony M. Zeenny, Marwan Akel and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:163
  10. This study aimed to assess the general public's perception of services provided by community pharmacies, their willingness to utilize these services, their satisfaction with and understanding of community phar...

    Authors: Yapp Wen Xuan, Hui Poh Goh, Inayat Ur Rehman, Naeem Shafqat, Yaser Mohammed Al-Worafi, Long Chiau Ming and Andi Hermansyah
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:162
  11. Patients with polypharmacy suffer from complex medical conditions involving a large healthcare burden. This study aimed to describe the characteristics and utilization of primary care (PC) and hospital care (H...

    Authors: Jaime Barrio-Cortes, Beatriz Benito-Sánchez, Ana Isabel Villimar-Rodriguez, Miguel Rujas, Peña Arroyo-Gallego, Jim Carlson, Beatriz Merino-Barbancho, Ana Roca-Umbert, Andrés Castillo-Sanz, Francisco Lupiáñez-Villanueva, Giuseppe Fico and Tomás Gómez-Gascón
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:161
  12. Vaccine hesitancy poses a global challenge and is acknowledged to be a complex, multifactorial phenomenon. Of particular concern is hesitancy among health professionals, as this may also impact their advocacy ...

    Authors: Moza Al Hail, Pallivalapila Abdulrouf, Derek Stewart, Wessam Elkassem, Rajvir Singh, Rasha Al Enany, Aftab Mohammed Azad, Asma Tarannum and Binny Thomas
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:160
  13. Understanding general public's experiences of using drive-thru pharmacies during COVID-19 in different countries is imperative for establishing these services by standardizing global guidelines for drive-thru ...

    Authors: Bayan F. Ababneh, Siew Chin Ong, Louai Alsaloumi, Hisham Z. Aljamal and Rabia Hussain
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:159
  14. The coronavirus disease 2019 (COVID-19) pandemic has been the defining public health emergency of our time. In Switzerland, messenger RNA (mRNA) vaccines were and still are widely utilized as a critical compon...

    Authors: Tim Killeen, Vanessa Kermer and Rahel Troxler Saxer
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:158

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2023 16:167

  15. A comprehensive guideline named “Diagnostic Therapeutic Flow Chart for Covid-19″ (DTFC) was released by the Scientific Committee of Covid-19 of Iran’s Ministry of Health and Medical Education and regularly was...

    Authors: Amir H. Zargarzadeh, Zoha Abdi and Sarah Mousavi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:157
  16. In many countries the community pharmacist’s role includes collecting prescription medicine co-payments at the point of dispensing. This is a context which can provide unique insights into individuals’ access ...

    Authors: Elizabeth F. Peacocke, Adam Fusheini and Pauline Norris
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:156
  17. There is growing interest in pharmaceutical innovation in low- and middle-income countries (LMICs), but information on existing activities, capacities, and outcomes is scarce. We mapped available data at the g...

    Authors: Marcela Vieira, Tatiana Andia, Obaida Karim, Sanjida Ahmed Srishti, Sebastian Alfonso Pineda, Adrian Alonso Ruiz, Kaitlin Large, Yiqi Liu, Suerie Moon, Nahitun Naher, Azizah Siddiqui and Syed Masud Ahmed
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:155
  18. Fluoroquinolones (FQs) is a distinct class of antibiotics which are prescribed and used quite frequently worldwide, despite the box warnings (BW) issued by Food and Drug Administration (FDA). Literature has sh...

    Authors: Muhammad Abbas, Kashif Kashmiri, Inayat Ur Rehman, Zahid Ali, Aziz Ur Rahman, Asad Khalil, Long Chiau Ming, Muhammad Shafique and Tahir Mehmood Khan
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:154
  19. Pharmacy professionals are experts in therapeutic knowledge, experience, and skills that are used to ensure desired patient outcomes, utilizing the best available clinical evidence and interventions in collabo...

    Authors: Ewunetie Mekashaw Bayked, Getachew Nigatu Taye, Segenet Zewdie, Teshager Aklilu, Mesfin Haile Kahissay and Husien Nurahmed Toleha
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:152
  20. Availability of the health commodities in public health facilities in Tanzania remains a challenge, and has been reported to be below 70%. Moreover, Medical Stores Department’s capacity to supply health commod...

    Authors: Daniel Pyuza, Shiferaw Mitiku, Omary Swalehe, Vedaste Kagisha and Kato Jonas Njunwa
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:150
  21. The popular use of herbal medicines necessitates national regulatory authorities to have efficient mechanisms for the control of these products including marketing authorization (MA) and safety follow-up. Herb...

    Authors: Alambo K. Mssusa, Lone Holst, Godeliver Kagashe and Sheila Maregesi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:149
  22. Medication errors are the most common cause of preventable adverse drug events at the emergency ward.

    Authors: Saron Naji Gebremariam, Faisel Dula Sema, Abdisa Gemedi Jara, Banchamlak Teferi Mekonen and Gizework Alemnew Mekonnen
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:148
  23. Private pharmacies are the first point of contact for the public regarding acquisition of medicines and other pharmaceuticals in many low- and middle-income countries including Uganda. Most antimicrobial stewa...

    Authors: David Musoke, Grace Biyinzika Lubega, Mimi Salome Gbadesire, Stephanie Boateng, Belinda Twesigye, Jagdeep Gheer, Betty Nakachwa, Michael Obeng Brown, Claire Brandish, Jody Winter, Bee Yean Ng, Kate Russell-Hobbs and Linda Gibson
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:147
  24. Vaccines require cold chain equipment (CCE) to ensure quality and potency, yet the risk of CCE failing is well-documented, often due to lack of equipment maintenance. While general barriers to a reliable CCE m...

    Authors: Wendy Prosser, Nicole Danfakha, Brittany Thurston, Aminta Gueye, Samira Matan, Cheikh Tidiane, Emily Kitts, Ibrahim Alkassoum, Yannick Agui, Abdoulaye Brah-Bouzou, Harouna Dembo and Mata Garba
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:146
  25. Delivery of quality healthcare is significantly based on the level of commitment among health facilities. This includes building a strong system with the continued availability of tracer commodities. Human res...

    Authors: Japheth Araka Ayako, Peter Ndirangu Karimi, Eugene Rutungwa, Joseph Lune Ngenzi, Kelvin Wangira Nyongesa, Racheal Habona Jillo, Miheso Hassler Kavere and Abdul Galgalo Shambaro
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:145
  26. Effective Vaccine Management (EVM) initiative provides the platform needed to monitor and assess the vaccine supply chain system to identify strengths and weaknesses of the system at all levels and enhance the...

    Authors: Green Sadru, Mulatedzi Makhado, Omary Swalehe, Stany Banzimana, Domina Asingizwe and Shital Mahindra Maru
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:144
  27. Epidemiological data on medication errors severity are scarce. The assessment of the prevalence and severity of medication errors may be limited because of several reasons, including a lack of standardization ...

    Authors: Lindemberg Assunção-Costa, Charleston Ribeiro Pinto, Juliana Ferreira Fernandes Machado, Cleidenete Gomes Valli and Luis Eugenio Portela Fernandes de Souza
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:143
  28. Routine vaccine is a cost-effective health intervention against vaccine preventable diseases (VPD). Tremendous gains have been realized since the introduction of vaccines. Despite the gains, access to the life...

    Authors: Billy Said Mkamba, Eugene Rutungwa, Peter Ndirangu Karimi and Joseph Lune Ngenzi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:142
  29. Public health emergencies raise significant concerns about corruption and accountability; however, these concerns can manifest in different ways across diverse locations. For instance, more developed countries...

    Authors: Obinna Onwujekwe, Charles Orjiakor, Pamela Ogbozor, Ifunanya Agu, Prince Agwu, Tom Wright, Dina Balabanova and Jillian Kohler
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:141
  30. Effective management of sexually transmitted infections (STIs) is crucial in the control and spread of these infections in health systems. Community pharmacies are usually the first port of call in Ghana for m...

    Authors: Araba Ata Hutton-Nyameaye, Farrukh Ishaque Saah, Israel Bedzina, Samuel Owusu Somuah, Kofi Boamah Mensah, Kwabena Obeng Duedu and Kwame Ohene Buabeng
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:140
  31. In India, states have licensed the manufacture of large numbers of fixed-dose combination (FDC) drugs without the required prior approval of the central regulator. This paper describes two major regulatory ini...

    Authors: Petra Brhlikova, Aashna Mehta, Patricia McGettigan, Allyson M. Pollock, Peter Roderick and Habib Hasan Farooqui
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:139
  32. There has been an increasing demand to reimburse high-cost medicines, through public health insurance schemes in Thailand.

    Authors: Dimple Butani, Dian Faradiba, Saudamini Vishwanath Dabak, Wanrudee Isaranuwatchai, Evan Huang-Ku, Kumaree Pachanee, Budsadee Soboon, Anthony J. Culyer and Yot Teerawattananon
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:138
  33. Adherence to evidence-based standard treatment guidelines (STGs) enable healthcare providers to deliver consistently appropriate diagnosis and treatment. Irrational use of antimicrobials significantly contribu...

    Authors: Minyahil Tadesse Boltena, Mirkuzie Woldie, Yibeltal Siraneh, Veronica Steck, Ziad El-Khatib and Sudhakar Morankar
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:137
  34. Authors: Joya Namnoum, Aline Hajj, Katia Iskandar, Hala Sacre, Marwan Akel, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:136

    The original article was published in Journal of Pharmaceutical Policy and Practice 2023 16:128

  35. Early notification of impending drug shortages is essential for mitigating or preventing shortages. Since 2019 pharmaceutical companies in the European Union (EU) and European Economic Area (EEA) must notify a...

    Authors: Reko Ravela, Marja Airaksinen and Alan Lyles
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:135
  36. Health supplements and natural products are widely used by the general public to support physical function and prevent disease. Additionally, with the advent of e-commerce, these products have become easily ac...

    Authors: Ju-Ying Ang, Guat-See Ooi, Fatimatuzzahra’ Abd.Aziz and Seng-Fah Tong
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:134
  37. Medication-related problems (MRPs) contribute significantly to preventable patient harm and global healthcare expenditure. Vulnerable populations, including Indigenous Australians (please note that the use of ...

    Authors: Jack C. Collins, Jie Hu, Sara S. McMillan, Claire L. O’Reilly, Sarira El-Den, Fiona Kelly, Jean Spinks, Toni Riley and Amanda J. Wheeler
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:133
  38. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used over-the-counter medications for the treatment of pain, fever, and inflammation. Gastrointestinal problems and renal complications are t...

    Authors: Hadeer Ehab Barakat, Christine Nazir Aziz and Salwa Selim Ibrahim Abougalambou
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:132
  39. Drug–drug interactions (DDI) are known to increase the risk of morbidity and mortality, and adversely affect the patient's quality of life. The study was to assess healthcare professional's (HCP) knowledge of ...

    Authors: Salwa Selim Ibrahim Abougalambou and Tief Naif Alenezi
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:131
  40. Complex dosage regimens and the high incidence of adverse events associated with warfarin therapy can affect the health-related quality of life (HRQoL) and willingness to pay (WTP) among patients on warfarin. ...

    Authors: Nattanichcha Kulthanachairojana, Krittaphas Kangwanrattanakul, Thitiya Khongmee, Nampratai Pawasan, Sitanan Chityam and Suphannika Pornwattanakavee
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:130
  41. Competencies refer to the knowledge, skills, attitudes, and behaviors individuals develop through education, training, and experience. These competencies can be formulated into a framework to support practitio...

    Authors: Joya Namnoum, Aline Hajj, Katia Iskandar, Hala Sacre, Marwan Akel, Rony M. Zeenny, Chadia Haddad and Pascale Salameh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:128

    The Correction to this article has been published in Journal of Pharmaceutical Policy and Practice 2023 16:136

  42. Expansion of hospital service models was one of the strategies implemented to manage the COVID-19 pandemic through virtual models of care. COVID-19 patients were hospital inpatients transferred to virtual ward...

    Authors: H. Laetitia Hattingh, Catherine Edmunds and Brigid M. Gillespie
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:127
  43. HPV vaccination of adolescent girls is the primary strategy for cervical cancer prevention but in Ethiopia, it lacks emphasis. Despite different studies done and found a highly variable level of parents’ willi...

    Authors: Amare Zewdie, Abebaw Wasie Kasahun, Haimanot Abebe Adane and Ayenew Mose
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:126
  44. After the era of the COVID-19 pandemic, the role of pharmacists was emphasized in the battle against highly spreading and infectious diseases like human Monkeypox (hMPV).

    Authors: Asmaa A. Elsayed, Hoda M. Rabea, Salman Ahmed Salman and Engy A. Wahsh
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:125
  45. Healthcare systems in both developing and developed countries were not free from prescription errors. One of the effects of prescription errors is irrational prescribing. According to the estimation of the Wor...

    Authors: Yeniewa Kerie Anagaw, Liknaw Workie Limenh, Derso Teju Geremew, Minichil Chanie Worku, Misganaw Gashaw Dessie, Tewodros Ayalew Tessema, Teshome Bitew Demelash and Wondim Ayenew
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:124
  46. Paraquat, one of the most widely used herbicides, poses a significant risk of mortality through self-poisoning and subsequent multiple organ failure. The primary objective aimed to identify the factors associa...

    Authors: Preechaya Tajai and Akarawat Kornjirakasemsan
    Citation: Journal of Pharmaceutical Policy and Practice 2023 16:123

Annual Journal Metrics

  • 2022 Citation Impact
    4.2 - 2-year Impact Factor
    1.266 - SNIP (Source Normalized Impact per Paper)
    0.574 - SJR (SCImago Journal Rank)

    2023 Speed
    28 days submission to first editorial decision for all manuscripts (Median)
    104 days submission to accept (Median)

    2023 Usage
    852,978 downloads
    963 Altmetric mentions